Treatment of A549 or primary human NSCLC cells with SAH-JGZ4 suppressed the interactions of TRIB3–EGFR and EGFR–PKCα (Supplementary Fig. 6a, b). This evidence concerns the gene PRKCA and non-small cell lung carcinoma.